Abstract: Deep-sea fungi, the fungi that inhabit the sea and the sediment at depths of over 1000 m below the surface, have become an important source of industrial, agricultural, and nutraceutical compounds based on their diversities in both structure and function. Since the first study of deep-sea fungi in the Atlantic Ocean at a depth of 4450 m was conducted approximately 50 years ago, hundreds of isolates of deep-sea fungi have been reported based on culture-dependent methods. To date more than 180 bioactive secondary metabolites derived from deep-sea fungi have been documented in the literature. These include compounds with anticancer, antimicrobial, antifungal, antiprotozoal, and antiviral activities. In this review, we summarize the structures and bioactivities of these metabolites to provide help for novel drug development.
Introduction
Fungi are well known for their vast diversity of secondary metabolites, which include many life-saving drugs and highly toxic mycotoxins [1] . Deep-sea fungi are the fungi that inhabit the sea and its sediment at a depth of over 1000 m below the surface [2] . Although the conditions in deep-sea environments are extreme and can be characterized by the absence of sunlight irradiation, predominantly human beings [40] . Therefore, seeking for high-efficiency, low-toxicity anticancer agents from deep-sea fungi has become one of the research subjects in the current pharmacy field.
Polyketides Compounds
Eight new chromones, engyodontiumones A-H (1) (2) (3) (4) (5) (6) (7) (8) , and eight known polyketides (9) (10) (11) (12) (13) (14) (15) (16) (Figure 1 ) have been isolated from the deep-sea fungus Engyodontium album DFFSCS021. These polyketide compounds show a significant selective cytotoxicity against human histiocytic lymphoma U937 cell line with IC50 of 4.9-8.8 μM. In addition, compounds 8, 12, and 13 exhibit mild antibacterial activity against Escherichia coli and Bacillus subtilis, and compound 12 shows potent antilarval activity against barnacle Balanus amphitrite larval settlement [41] . Nine new C9 polyketides, named aspiketolactonol (17) , aspilactonols A-F (18) (19) (20) (21) (22) (23) , aspyronol (25) , and epiaspinonediol (27) , together with five known polyketides, (S)-2-(2′-hydroxyethyl)-4-methyl-γ-butyrolactone (24) , dihydroaspyrone (26) , aspinotriol A (28), aspinotriol B (29) , and chaetoquadrin F (30) (Figure 2 ), have been isolated from the secondary metabolites of Aspergillus sp. 16-02-1, which was isolated from a deep-sea sediment at a Lau Basin hydrothermal vent (depth 2255 m, temperature 114 °C) in the southwest of the Pacific Ocean. All of these compounds show strong cytotoxic activities against human cancer cell lines such as K562, HL-60, HeLa, and BGC-823 [42] . Five new nitrogen-containing sorbicillinoids, named sorbicillamines A-E (31-36) (Figure 3 ), have been isolated from an agitated culture of a deep-sea fungus Penicillium sp. F23-2. The structures of 31 to 36, including absolute configurations, were determined based on MS, NMR, and circular dichroism (CD) data. Unfortunately, all these compounds show weak cytotoxicity (IC50 > 10 μM) against the HeLa, BEL-7402, HEK-293, HCT-116, and P388 cell lines. Moreover, the strain F23-2 is able to produce indole alkaloids and terpenoids when it is cultured under static conditions [43] . Two highly oxygenated polyketides, penilactone A (37) and B (38) (Figure 4) , containing a new carbon skeleton formed from two 3,5-dimethyl-2,4-diol-acetophenone units and a γ-butyrolactone moiety, have been isolated from a fungus named Penicillium crustosum PRB-2, which was derived from deep water environments of the Antarctic Ocean. Penilactones A and B possess antipodal absolute stereochemistry and show weak antitumor activity. However, penilactone A exhibits weak cytotoxic activity against NF-κB (40%) at the concentration of 10 mM [25] .
Two new fungal hybrid polyketides, cladosin F (39) and G (40) (Figure 4 ), with a rare 6(3)-enamino-8,10-dihydroxy-tetraketide system have been discovered from the deep-sea-derived fungus Cladosporium sphaerospermum 2005-01-E3, guided by the OSMAC approach. Both exhibit weak in vitro antitumor activity [44] . (Figure 6 ), which were isolated from the crude extract of the deep-sea fungus Penicillium sp. metabolites. Compounds 48 and 49 show slight cytotoxic effects against MCF-7 cells and A549 cells [46] .
Compounds ergosterol (50) and ergosterol peroxide (51) (Figure 6 ) have been isolated from the cultures of the deep-sea fungus Penicillium sp. F00120, which was collected from the northern South China Sea at a depth of 1300 m [47] . Compound 51 also has been isolated from the deep-sea-derived fungus Aspergillus sp. CXCTD-06-6a [48] . Both compounds show good cytotoxicity (27.2%-31.5%) against the HeLa cell line at 10 μM [47] . (17R)-17-Methylincistererol (52) and cerevisterol (53) (Figure 7) were isolated from the deep-sea fungus Aspergillus sydowi by a bioassay-guided method. Compound 52 has been considered as a highly degraded product of sterol, while compound 53 is a common metabolite of fungi. Both exhibit cytotoxicity [49] . Shang et al. (2012) [50] also reported compound 53 together with compound 54 (Figure 7 ), which was isolated from the deep-sea fungus Penicillium commune SD-118. All of them show a slight cytotoxicity against MCF-7 [50]. 
Indole Derivatives
Three new prenylated indole alkaloids, including two β-carbolines, penipaline A (55) and B (56) , and one indole carbaldehyde derivative, penipaline C (57), as well as two known indole-derived analogs (58, 59) (Figure 8 ), have been isolated from the metabolites of the deep-sea fungus Penicillium paneum SD-44, which was cultivated in a 500-L bioreactor. All these metabolites show cytotoxicity against A549 (IC50: 20.4-21.5 μM) and HCT-116 (IC50: 14.9-18.5 μM) cell lines [51] .
5-Chlorosclerotiamide (60) and 10-epi-sclerotiamide (61) (Figure 8 ) are the secondary metabolites of the deep-sea fungus Aspergillus westerdijkiae DFFSCS013, which show excellent cytotoxicity against K562 cell line with IC50 of 44 μM and 53 μM, respectively [52] . 
Sesquiterpenoids
Chemical investigation of the Penicillium sp. PR19 N-1 isolated from the Antarctic deep-sea has yielded five new eremophilane-type sesquiterpenes (62-66) ( Figure 9 ). These compounds show strong cytotoxicity against HL-60 cells (IC50: 28.3-45.8 μM) and the A-549 cells (IC50: 5.2-82.8 μM) [53] . In 2013, Wu et al. [24] isolated a new chloro-trinoreremophilane sesquiterpene 67, three new chlorinated eremophilane sesquiterpenes (68) (69) (70) , and a known compound, eremofortine C (71) (Figure 9 ), from the same strain, PR19N-1. They found that all the compounds (67-71) exhibit cytotoxic activity against HL-60 and A549 cell lines. Particularly, compound 67 shows great cytotoxicity against HL-60 and A549 cell lines with IC50 of 11.8 and 12.2 μM, respectively [24] .
In 2010, Chen et al. reported a new sesquiterpene, hydroquinone (72) (Figure 9 ), which was isolated from the metabolites of the deep-sea fungus Phialocephala sp. This compound displays strong cytotoxic activity against P388 and K562 cells with IC50 of 0.16 μM and 0.05 μM, respectively [54] . A compound (2′S)-4-methoxy-3-(2′-methyl-3′-hydroxy) propionyl-methyl benzoate (82) (Figure 12 ) has been isolated from the metabolites of the deep-sea fungus Aspergillus sp. 16-02-1. This compound possesses 34.5%, 25.2%, 3.2%, and 15.5% cytotoxicity against human cancer cell lines K562, HL-60, HeLa, and BGC-823, respectively, at 100 μg/mL [56] .
A secondary metabolite of 5-hydroxy-2-methoxy benzoic acid (83) ( Figure 12 ) was isolated from the deep-sea fungus Aspergillus sp. CXCTD-06-6a, which shows 7.29% of cytotoxic activity against the HeLa cell line at 1.68 μg/mL [48] .
An aromatic compound (84) (Figure 12 ) has been isolated from the metabolites of the deep-sea sediment-derived Penicillium commune SD-118. It exhibits moderate cytotoxicity against the SW1990 cell line with IC50 of 0.11 mM [50] . A new methyl 2-(4-((2-hydroxy-3-methylbut-3-en-1-yl)oxy)phenyl) acetate (85), together with five known compounds (86-90) (Figure 13 ), has been isolated from the culture of the deep-sea fungus Aspergillus westerdijkiae SCSIO 05233. All of these display weak cytotoxic activities. Compound 89 displays weak antiproliferation activities towards K562 and promyelocytic HL-6 (IC50: 25.8-44.9 mM), while compound 90 shows strong antifouling activity with EC50 of 27.5 mM [57] . (Figure 16 ), was isolated from the deep-sea fungus Phialocephala sp. FL30r. Trisorbicillinone A shows cytotoxicity against P388 and HL60 cells with IC50 of 9.1 and 3.1 μM, respectively [59] .
Two new bisorbicillinoids, named oxosorbiquinol (102) and dihydrooxosorbiquinol (103) (Figure 16 ), have been isolated from the deep-sea fungus Phialocephala sp. Both of them show cytotoxicity (IC50: 8.9-103.5 μM) against P388, A549, HL60, BEL-7402, and K562 cell lines [60] . 
Other Compounds
A novel cyclopentenone, trichoderone (120), and a known compound, cholesta-7,22-diene-3b, 5a,6b-triol (121) (Figure 19 ), were identified from the deep-sea fungus Trichoderma sp., which was isolated from the deep-sea sediment of the South China Sea. Compound 120 shows more than 80% cytotoxicity against A549 and NCIH460 cancer cell lines. The selectivity index for 120 was greater than 100. The two compounds also act as enzyme inhibitors against HIV protease and Taq DNA polymerase [18] . A known antibacterial compound, xanthocillin X (126) (Figure 20 ), was isolated for the first time from the deep-sea fungus Penicillium commune SD-118. This compound displays not only remarkable antimicrobial activity against Staphylococcus aureus and Escherichia coli with MIC of 1-64 μg/mL, but also significant cytotoxicity against MCF-7, HepG2, H460, HeLa, DU145, and MDA-MB-231 cell lines (IC50: 7-22 μg/mL) [50, 63] .
One new sesquiterpene quinone, named penicilliumin A (127) (Figure 20 ), was isolated from the deep-sea fungus Penicillium sp. F00120. It inhibits in vitro proliferation of mouse melanoma (B16), human melanoma (A375), and human cervical carcinoma (HeLa) cell lines with IC50 of 0.08, 0.06, and 0.12 mM, respectively [47] . Seven gliotoxin-related compounds including two new metabolites, bis(dethio)-10a-methylthio3a-deoxy-3,3a-didehydrogliotoxin (132) and 6-deoxy-5a,6-didehydrogliotoxin (133), and five known metabolites (134-138) (Figure 22 ) have been isolated from the fungus Penicillium sp. strain JMF034, which was obtained from the deep-sea sediments of Suruga Bay, Japan. All these types of compounds exhibit significant cytotoxic activity against P388 (IC50: 0.02-3.40 μM), whereas compounds 136-138 containing a disulfide or tetrasulfide bond show potential inhibitory activity against histone methyltransferase (HMT) G9a (IC50: 2.1-6.4 μM) [65] . 
Antibacterial
Antimicrobials are the most important drugs to protect human beings from infective diseases. Deep-sea fungi are one of the potential pools for screening antimicrobial metabolites, which can be developed into new drugs. 
Citromycetin Analogue
A new citromycetin analogue, diorcinol (165) (Figure 26 ), has been isolated from the metabolites of Ascomycota sp. Ind19F07, which was collected from the deep-sea sediment in the Indian Ocean.
Based on in vitro tests, compound 165 shows strong antibacterial activity against both Gram-positive and -negative bacteria such as Acinetobacter baumanii, Escherichia coli, Enterococcus faecalis, and Staphylococcus aureus [68] . 
Other Compounds
Recently, [23] have evaluated the antimicrobial activities of the secondary metabolites produced by eight novel deep-sea-derived fungal species, Acremonium implicatum DFFSCS001 (AI001), Aspergillus westerdijkiae DFFSCS013 (AW013), Alternaria tenuissima DFFSCS003 (AT003), Cladosporium cladosporioides DFFSCS016 (CC016), Cladosporium sphaerospermum DFFSCS019 (CS019), Engyodontium album DFFSCS021 (EA021), Geomyces vinaceus DFFSCS022 (GV022), and Tritirachium sp. DFFSCS034 (TS034). These fungal species were isolated from sediments of the South China Sea [23] , and almost all the ethyl acetate extracts of the fungal species show strong antibacterial activity against two larval-settlement-inducing bacteria Loktanella hongkongensis and Micrococcus luteus, and one marine pathogenic bacterium. Based on bioassay-guided isolation technique, they have isolated five compounds (166-170) (Figure 27 ) from the extract of Aspergillus westerdijkiae DFFSCS013 that show antifouling activity against Bugula neritina larval settlement with an EC50 of 6.4-34.9 μg/mL [25] . 
Antiviral

Polyketides
Although many polyketide compounds have been identified, the compounds derived from deep-sea fungi with antiviral activity are rare. Only one fungal hybrid polyketide with a new structure, cladosin C (171) (Figure 28 ), has been reported from the deep-sea fungus Cladosporium sphaerospermum 2005-01-E3. However, this compound shows good antiviral activity against influenza A H1N1 virus with an IC50 of 276 μM [9] . 
Hydroxyphenylacetic Acid
Compound 178 (Figure 30 ) has been reported from the deep-sea-derived fungus Aspergillus westerdijkiae SCSIO 05233 and shows strong antifouling activity with an EC50 of 8.8 mg/mL [57] . 
Antifungal
One compound, p-hydroxyphenopyrrozin (179) (Figure 31) , with a new structure has been isolated from the deep-sea fungus Chromocleista sp. and characterized on the basis of mass spectroscopy, NMR experiments, derivatization, and X-ray crystallography studies. The MIC of this compound is 25 μg/mL against Candida albicans [1] . In 2013, Liu et al. reported a compound (180) (Figure 31 ) that was isolated from the deep-sea fungus Aspergillus candidus and shows great growth inhibition against Candida albicans [67] . 
Compounds with Other Bioactivities
Two citrinin type compounds, phenol A acid (181) and penicitrinone A (182) (Figure 32) , with anti-Aβ peptide aggregation inhibition activity have been isolated from the deep-sea fungus Aspergillus sp. SCSIOW 3, which show Aβ42 assembling inhibition activity (40.3%-72.3%) at 100 μM [70] . 
Conclusions
The fungi in deep-sea environments are very diverse and abundant, making them a versatile reservoir of metabolites with both new structures and bioactivities that can be of potential use, acting as leading compounds to synthesize new modern medicine. Although the research on deep-sea fungi is not as up-to-date as the research on fungi in other environments such as terrestrial soil, fresh water, and shallow marine areas due to difficulties in both sample collection and fungal cultivation methods, more and more fungi have been cultivated from the deep sea based on culture-dependent methods. These deep-sea fungi can provide a potential source for natural bioactive product screening and new drug discovery. Up to now, more than 180 new and/or bioactive secondary metabolites from deep-sea fungi with broad bioactivities, such as anticancer, antimicrobial, antifungal, anti-larval settlement, and antiviral, have been described in the literature. Most of the investigated bioactive compounds exhibit cytotoxic activity, then antimicrobial activity. These bioactive compounds not only help deep-sea fungi to defend themselves against predators in the natural ecosystem, but also have the potential of becoming treatments for human diseases and probes for new biological targets. Work to isolate fungi from deep-sea environments and characterize their bioactive metabolites is underway and is of increased importance due to the urgent need for new drugs to overcome emerging and drug-resistant diseases.
